LifeForce Hospitals

02.gif (21371 bytes)

Home
Up
CA-Amyline Cardio
MD-Amylox
Rotan
Amyloxine

[FrontPage Save Results Component]
 

Clinical Trials being conducted by LifeForce.

Carcinoma  Clinical Trial - Amyloxine®
LifeForce Research  is currently recruiting clinical investigators and patients for participation in the ACSA  trial - (Amyloxine®Non-small cell Carcinoma Study Assessment). For more information about Amyloxine®, please visit our Amyloxine® page.

The 14 week investigation is underway at centers in North America, Mexico, South America, and Europe and is actively recruiting patients with a diagnosis of Non-small cell Carcinoma. For more information on the trial and eligibility, please fill out the form below and you will be contacted directly.


Arthritis Clinical Trial - Rotan®
At present Rotan®  is being investigated in volunteers undergoing diagnostic electrophysiologic studies to assess safety and tolerability in a Phase I trial. Future studies may investigate the role of Rotan®  in the treatment of Arthritis. If you are interested in receiving information about or participating in any future clinical trials of Rotan®, please fill out the form below and you will be contacted directly. For more information about Rotan®, please visit our Rotan® page.

ARMD (Macular Degeniration) Clinical Trial - MD-Amylox®

MD-Amylox® is being investigated in volunteers  undergoing diagnostic electrophysiologic studies  to assess safety and tolerability in Phase I trail.  Future studies may investigate the role of MD-Amylox® in the treatment of ARMD.  If you are interested in receiving information about or participating in any futrue clinical trials of MD-Amylox® please fill out the form below and you will be contacted directly.  For more information about MD-Amylox®, please visit our MD-Amylox® page.

Coronary Artery Disease - CA-Amyline®

The Study  investigation will be at centers in North America, Europe, Canada, Mexico  and is actively recruiting patients with a diagnosis of coronary artery disease who have symptom-limited exercise duration in conjunction with ECG changes indicative of ischemia. For more information on the trial and eligibility, please fill out the form below and you will be contacted directly.

 

 

Name

Firm (if applicable)

Address

Address 2

City 

State

Zip

Country

Phone

E-mail

Please select the description that best describes you:

A doctor interested in conducting trials.
A doctor with a potential patient for a clinical trial.
A patient interested in a clinical trial.

Please select the clinical trial that you are interested in:

carsonima (Cancer) clinical trial - Amyloxine®
future arthritius clinical trials - Rotan®                            ARMD (Macular Degeniration) Clinical Trial - MD-Amylox®

Coronary Artery Disease - CA-Amyline®

Comments:

IF Form server does not work please Email Info Request to :

Copyright 1999, LifeForce Research Hospitals,Int.

Please E-Mail for information to participat :medmail@usa.net

 

Home ] Up ] CA-Amyline Cardio ] MD-Amylox ] Rotan ] Amyloxine ]

 

Send mail to medmail@usa.net with questions or comments about this web site.
Copyright © 1999 LifeForce Hospitals Webserver Location Italy